{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:25:19Z","timestamp":1782512719292,"version":"3.54.5"},"reference-count":108,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"vor","delay-in-days":10728,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1982,9,10]]},"abstract":"<jats:p>Trazodone is a new antidepressant agent that was recently introduced in the United States. It has a unique pharmacological profile that is not typical of either tricyclic or monoamine oxidase inhibitor antidepressants. As such it represents a new class of antidepressant drugs. The efficacy of trazodone has been clearly established in comparative studies with imipramine and amitriptyline. Major depression is the principal indication for its use, but good results have been shown in a wide variety of depressive subtypes. Of particular importance is the low frequency of adverse reactions seen with this drug.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1982.tb03193.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T16:58:34Z","timestamp":1450285114000},"page":"255-265","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Trazodone Hydrochloride: A Wide Spectrum Antidepressant with a Unique Pharmacological Profile"],"prefix":"10.1002","volume":"2","author":[{"given":"Anastase","family":"Georgotas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L","family":"Forsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Gershon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"745","article-title":"Chemistry of trazodone","volume":"15","author":"Palazzo G.","year":"1973","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_3_2","first-page":"755","article-title":"Clinical experience with a new psychotropic drug, trazodone: a review of literature","volume":"15","author":"Udabe RU.","year":"1973","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(68)90069-5"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198111001-00008"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(81)73499-6"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198111001-00002"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760210019001"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760270019001"},{"key":"e_1_2_1_10_2","volume-title":"The biology of the major psychoses: a comparative analysis","author":"Goodwin FK","year":"1975"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-197405000-00008"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198111001-00003"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750200062013"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.129.4.342"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(78)90094-1"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(80)90152-1"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(80)90197-5"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1977.tb11393.x"},{"key":"e_1_2_1_19_2","first-page":"133","article-title":"Effects of trazodone on behavior and brain amine content of mice","volume":"19","author":"Massotti M","year":"1976","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00429685"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198111001-00004"},{"key":"e_1_2_1_22_2","first-page":"18","volume-title":"Trazodone: modern problems of pharmacopsychiatry","author":"Boissier JR","year":"1974"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","unstructured":"GarattiniS.Biochemical studies with trazodone. See reference 21 pp29\u201346.","DOI":"10.1159\/000395599"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","unstructured":"YamatsuK KanekoT YamanishiYet al.A possible mechanism of central action of trazodone in rats. See reference 21 pp11\u20137.","DOI":"10.1159\/000395597"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1976.tb04095.x"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(76)90165-9"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(76)90364-7"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(81)90186-6"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1980.tb10947.x"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(80)90188-4"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","unstructured":"AngelucciL BolleP.Considerations on biochemical studies with trazodone. See Reference 21 pp65\u201375.","DOI":"10.1159\/000395603"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1979.tb11573.x"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","unstructured":"LongoVG CarolisDeScotti A.Pharmacological features of trazodone. See reference 21 pp4\u201310.","DOI":"10.1159\/000395595"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","unstructured":"DominoEF.Discussion on pharmacological features of trazodone. See reference 21 pp52\u20135.","DOI":"10.1159\/000395601"},{"key":"e_1_2_1_35_2","first-page":"749","article-title":"Pharmacology of trazodone","volume":"15","author":"Silvestrini B","year":"1973","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","unstructured":"GattiGL.Effects of trimeprazine trimeprimine and trazodone on conditioned behaviour of rats using a method of discriminated continuous avoidance. See reference 21 pp47\u201351.","DOI":"10.1159\/000395600"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-6989(79)80088-0"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198111001-00013"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(79)90496-5"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(79)90234-0"},{"key":"e_1_2_1_41_2","first-page":"540","article-title":"Systematic clinical studies with trazodone: methodological aspects","volume":"15","author":"Ban TA","year":"1973","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_42_2","first-page":"43","article-title":"Proceedings: trazodone: clinical and biochemical studies I. an uncontrolled clinical trial in depression","volume":"12","author":"Pecknold JC","year":"1976","journal-title":"Psychopharmacol Bull."},{"key":"e_1_2_1_43_2","doi-asserted-by":"crossref","unstructured":"ParianteF.Clinical effect of intravenous trazodone administration in severe depression. See reference 21 pp176\u201381.","DOI":"10.1159\/000395615"},{"key":"e_1_2_1_44_2","first-page":"781","article-title":"Trazodone in the treatment of affective disorders","volume":"15","author":"Amin M","year":"1973","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_45_2","first-page":"1","article-title":"Studio clinico controllato dell'attivita anti\u2010depressiva e ansiolitica di un nuovo pisicofarmaco I' AF\u20101161","volume":"72","author":"Cianchetti C","year":"1968","journal-title":"Gazz Intern Med Chir."},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(80)90209-9"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.136.2.154"},{"key":"e_1_2_1_48_2","first-page":"1","article-title":"Additional data on the antidepressant action of a new psychodrug, AF\u20101161","volume":"49","author":"Cioffi F","year":"1969","journal-title":"Rass Int Clin Ter."},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198111001-00006"},{"key":"e_1_2_1_50_2","first-page":"390","article-title":"Trazodone, a new antidepressant: efficacy and safety in endogenous depression","volume":"40","author":"Kellams JJ","year":"1979","journal-title":"J Clin Psychiatry."},{"key":"e_1_2_1_51_2","first-page":"293","article-title":"The antidepressant effects of trazodone and inhibition of platelet serotonin reuptake","volume":"4","author":"Mann JJ","year":"1980","journal-title":"Commun Psychopharmacol."},{"key":"e_1_2_1_52_2","first-page":"25","article-title":"Trazodone in the treatment of depressed inpatients","volume":"15","author":"Trapp GA","year":"1979","journal-title":"Psychopharmacol Bull."},{"key":"e_1_2_1_53_2","first-page":"250","article-title":"Trazodone, a triazolopyridine derivative, in primary depressive disorder","volume":"51","author":"Feighner J.","year":"1980","journal-title":"J Clin Psychiatry."},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198111001-00008"},{"key":"e_1_2_1_55_2","first-page":"827","article-title":"Trazodone efficacy in depression: a double\u2010blind comparison with imipramine and placebo in day\u2010hospital type patients","volume":"25","author":"Fabre LF","year":"1979","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1980.tb02534.x"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(80)90200-2"},{"key":"e_1_2_1_58_2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000468443","article-title":"Trazodone in depression","volume":"15","author":"Wheatley D.","year":"1980","journal-title":"Int Pharmacopsychiatry."},{"key":"e_1_2_1_59_2","first-page":"1","article-title":"Clinical evaluation of AF\u20101161 in psychiatry. A cross\u2010over double\u2010blind trial","volume":"17","author":"Pariante F.","year":"1971","journal-title":"Riv Neuropsichiat Scien Aff."},{"key":"e_1_2_1_60_2","doi-asserted-by":"crossref","unstructured":"CassanoGB CastrogiovanniP ContiL.Clinical evaluation of trazodone in the treatment of depression. See reference 21 pp199\u2013204.","DOI":"10.1159\/000395618"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.6.803"},{"key":"e_1_2_1_62_2","first-page":"416","article-title":"Contributo clinico alla terapia delle depressioni endogene con un derivato della triazolpiridina","volume":"39","author":"Vinci M.","year":"1971","journal-title":"Osped Psichiat."},{"key":"e_1_2_1_63_2","first-page":"47","article-title":"A double\u2010blind study of trazodone","volume":"16","author":"Goldberg HM","year":"1980","journal-title":"Psychopharmacol Bull."},{"key":"e_1_2_1_64_2","first-page":"430","article-title":"Trazodone in the treatment of neurotic depression","volume":"41","author":"Goldberg HL","year":"1980","journal-title":"J Clin Psychiatry."},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198111001-00007"},{"key":"e_1_2_1_66_2","first-page":"845","article-title":"Differential antidepressant properties of trazodone and amitriptyline in agitated and retarded depression","volume":"28","author":"LaPierre YD","year":"1980","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1019592"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(80)90208-7"},{"key":"e_1_2_1_69_2","doi-asserted-by":"crossref","unstructured":"AgnoliA PiccioneM CasacchiaMet al.Trazodone versus desipramine: a double\u2010blind study on the rapidity of the antidepressive effect. See reference 21 pp190\u20138.","DOI":"10.1159\/000395617"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198111001-00010"},{"key":"e_1_2_1_71_2","first-page":"74","article-title":"Evaluation of trazodone in the treatment of anxiety","volume":"20","author":"Wheatley D.","year":"1976","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_72_2","doi-asserted-by":"crossref","unstructured":"SchwarzD BlendlM.Sedative and anxiety\u2010reducing properties of trazodone. See reference 21 pp146\u201356.","DOI":"10.1159\/000395610"},{"key":"e_1_2_1_73_2","first-page":"776","article-title":"Trazodone in the treatment of schizophrenias","volume":"15","author":"Galvan L","year":"1973","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_74_2","first-page":"485","article-title":"A controlled clinical study of trazodone in chronic schizophrenic patients with pronounced depressive symptomatology","volume":"23","author":"Singh AN","year":"1978","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_75_2","first-page":"540","article-title":"Comprehensive clinical studies with trazodone","volume":"15","author":"Ban TA","year":"1973","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_76_2","first-page":"11","article-title":"A placebo\u2010controlled clinical study with trazodone in schizophrenic patients","volume":"13","author":"Lehmann HE","year":"1977","journal-title":"Psychopharmacol Bull."},{"key":"e_1_2_1_77_2","first-page":"13","article-title":"A standard\u2010controlled clinical study with trazodone in schizophrenic patients","volume":"13","author":"Deutsch M","year":"1977","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_78_2","first-page":"195","article-title":"Interesse di un nuvov psicofarmaco aco nelle malattie internistiche a componente psicosomatica","volume":"11","author":"Pretolani E.","year":"1972","journal-title":"Clin Europ."},{"key":"e_1_2_1_79_2","doi-asserted-by":"crossref","unstructured":"AntonelliF DeGregorioM DionisioAet al.Trazodone in the treatment of neurosis. See reference 21 pp127\u201339.","DOI":"10.1159\/000395608"},{"key":"e_1_2_1_80_2","doi-asserted-by":"crossref","unstructured":"MiuraS.Preliminary clinical studies with trazodone in the treatment of neurotic patients. See reference 21 pp140\u20135.","DOI":"10.1159\/000395609"},{"key":"e_1_2_1_81_2","doi-asserted-by":"crossref","unstructured":"ShibaharaY.Clinical experiences with trazodone on various psycho\u2010neuroses in Japan. See reference 21 pp173\u20135.","DOI":"10.1159\/000395614"},{"key":"e_1_2_1_82_2","first-page":"789","article-title":"Trazodone and psychosomatic medicine","volume":"15","author":"Knobel M.","year":"1973","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_83_2","first-page":"167","article-title":"A placebo\u2010controlled double\u2010blind study of imipramine and trazodone in geriatric depression","volume":"69","author":"Gerner R","year":"1980","journal-title":"Proc Annu Meet Am Psychopathol Assoc."},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(81)90586-5"},{"key":"e_1_2_1_85_2","first-page":"216","article-title":"Treatment of geriatric depression with trazodone, imipramine, and placebo: a double\u2010blind study","volume":"41","author":"Gerner R","year":"1980","journal-title":"J Clin Psychiatry."},{"key":"e_1_2_1_86_2","first-page":"23","article-title":"Trittico e stati depressivi dell'eta involutiva","volume":"11","author":"Lucchi R.","year":"1975","journal-title":"Rassegna Geriatrica."},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198111001-00015"},{"key":"e_1_2_1_88_2","first-page":"769","article-title":"Trazodone in the treatment of organic brain syndromes, with special reference to psychogeriatrics","volume":"15","author":"Nair NPV","year":"1973","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_89_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000468290","article-title":"Trazodone by intravenous infusion in depressions secondary to organic disease","volume":"12","author":"Roccatgliata G","year":"1977","journal-title":"Int Pharmacopsychiatry."},{"issue":"15","key":"e_1_2_1_90_2","first-page":"105","article-title":"Alcohol withdrawal syndrome: treatment with trazodone","volume":"180","author":"Roccatagliata G","journal-title":"Int Pharmacopsychiatry."},{"key":"e_1_2_1_91_2","first-page":"368","article-title":"Blockage of acute opiate\u2010withdrawal symptoms by trazodone treatment","volume":"118","author":"Fedeli S","year":"1979","journal-title":"Boll Chim Farm."},{"key":"e_1_2_1_92_2","doi-asserted-by":"crossref","unstructured":"SaarmaJ.Trazodone \u2014 a review of literature. See reference 21 pp95\u2013109.","DOI":"10.1159\/000395606"},{"key":"e_1_2_1_93_2","doi-asserted-by":"crossref","unstructured":"MontaniniR.EEG findings in geriatric patients treated with trazodone. See reference 21 pp160\u20136.","DOI":"10.1159\/000395612"},{"key":"e_1_2_1_94_2","doi-asserted-by":"crossref","unstructured":"MuratorioA MagginiC CoccagnaGet al.Polygraphic study of all\u2010night sleep pattern in neurotic and depressed patients treated with trazodone. See reference 21 pp182\u20139.","DOI":"10.1159\/000395616"},{"key":"e_1_2_1_95_2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000468388","article-title":"Trazodone intravenously administered and plasma prolactin levels","volume":"14","author":"Roccatagliata G","year":"1979","journal-title":"Int Pharmacopsychiatry."},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1159\/000117828"},{"key":"e_1_2_1_97_2","first-page":"480","article-title":"Psychotropic drugs: influence on respiratory function","volume":"15","author":"Casali L","year":"1977","journal-title":"Int J Clin Pharmacol Biopharm."},{"key":"e_1_2_1_98_2","doi-asserted-by":"crossref","unstructured":"GunellaG.Trazodone's effects on patients with partial or total ventilatory insufficiency. See reference 21 pp167\u201372.","DOI":"10.1159\/000395613"},{"key":"e_1_2_1_99_2","first-page":"1","article-title":"Hypotensive effect on intraocular tension by AF\u20101161 (Trazodone)","volume":"98","author":"Daniele S","year":"1972","journal-title":"Annales di Ottalmologia e Clinica Oculistica."},{"key":"e_1_2_1_100_2","first-page":"410","article-title":"Experimental and clinical data indicating a potential use of trazodone in acute stroke","volume":"18","author":"Allori L","year":"1975","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_101_2","first-page":"424","article-title":"A comparative study of trazodone serum concentrations in patients with normal or impaired renal function","volume":"117","author":"Catanese B","year":"1978","journal-title":"Boll Chim Farm."},{"key":"e_1_2_1_102_2","doi-asserted-by":"crossref","unstructured":"FujitaT YamatoC TakahashiTet al.Absorption tissue distribution excretion and metabolism of14C\u2010labelled trazodone hydrochloride in rats and rabbits. See reference 21 pp56\u201364.","DOI":"10.1159\/000395602"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(00)97841-5"},{"key":"e_1_2_1_104_2","first-page":"341","article-title":"Pharmacokinetics of trazodone after different routes of administration","volume":"33","author":"Rurak A","year":"1981","journal-title":"Pol J Pharmacol Pharm."},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1981.tb01157.x"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1159\/000136707"},{"key":"e_1_2_1_107_2","first-page":"100","article-title":"Lack of anticholinergic side effects with a new antidepressant\u2010trazodone","volume":"41","author":"Gershon S","year":"1980","journal-title":"J Clin Psychiatry."},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt197926124"},{"key":"e_1_2_1_109_2","doi-asserted-by":"crossref","unstructured":"RivettKF BarcellonaPS.Toxicology of trazodone. See reference 21 pp76\u201386.","DOI":"10.1159\/000395604"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1982.tb03193.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1982.tb03193.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1982.tb03193.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:24:22Z","timestamp":1761042262000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1982.tb03193.x"}},"subtitle":["A Review of Its Neurochemical Effects, Pharmacology, Clinical Efficacy, and Toxicology"],"short-title":[],"issued":{"date-parts":[[1982,9,10]]},"references-count":108,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1982,9,10]]}},"alternative-id":["10.1002\/j.1875-9114.1982.tb03193.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1982.tb03193.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,9,10]]},"assertion":[{"value":"2012-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}